摘要
视网膜母细胞瘤(RB)的治疗已经到了挽救生命的同时挽救视力(life-saving and vision-saving care)的阶段。既要提高RB患儿的生存率,延长生存时间;同时也要保留眼球,提高生活质量。诊断不及时,不恰当的治疗,都会引起RB复发、向眼外蔓延和转移,保眼率降低,生存机会减少。随着对RB治疗的不断探索,新的治疗方式不断出现,如何正确选择、评价这些治疗方式,对RB患儿采取最安全有效的规范化治疗,达到远期治愈的效果,是临床医生需要切实考虑的问题。
The treatment for retinoblastoma(RB)has been reached the stage of life-saving and vision-saving care.It is necessary to improve the survival rate and prolong the life time of RB children,retaining the eyeball and improving the quality of life.If the diagnosis is not timely and the treatment is inappropriate,the tumor recurrence,extraocular spread and metastasis of retinoblastoma will occur.The rate of eye protection and the survival chance of RB children will be reduced.With the continuous exploration of RB therapy and the emergence of new treatment methods,how to correctly select and evaluate these treatment methods and to adopt the most safe and effective treatment for RB children,to achieve long-term cure effect,is an important problem which clinicians need to consider.
作者
魏文斌
周楠
Wei Wenbin;Zhou Nan(Beijing Tongren Eye Center,Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment,Beijing Ophthalmology&Visual Sciences Key Lab,Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China)
出处
《中华眼底病杂志》
CAS
CSCD
北大核心
2020年第6期413-418,共6页
Chinese Journal of Ocular Fundus Diseases
基金
首都卫生发展科研专项(首发2020-1-2052)
北京市科委科技计划项目(Z181100001818003)
北京市医院管理局"登峰"人才培养计划(DFL20150201)。